DeepMind Blog
May 16
Accelerating discovery of liver disease mechanisms
Filippo Menolascina uses Co-Scientist to identify new liver disease treatments and explain why existing drugs only help certain patients.
Uncovering repurposed medicines to fight liver fibrosis
Stanford geneticist uses Co-Scientist to help find new treatments for chronic liver disease and liver fibrosis.
Related stories
DeepMind Blog
May 16
Uniting biological toolkits for a new approach to ALS
Co-Scientist unites Boston Children’s Hospital and MIT’s labs to explore new RNA-based treatments for ALS.
DeepMind Blog
May 16
Finding the molecular switches behind new infectious diseases
Clare Bryant uses Co-Scientist to identify genetic triggers in emerging infectious diseases.
DeepMind Blog
May 18
Fast-tracking genetic leads to reverse cellular aging
Biologists use Co-Scientist to find novel factors that successfully rejuvenate human cells.
arXiv AI
Jul 7
A Precedent-Guided Co-Scientist for Side-Effect-Aware Drug Redesign
arXiv:2607. 02944v1 Announce Type: cross Abstract: We propose PRECEDE, a precedent-guided co-scientist for side-effect-aware drug redesign that revises a parent compound to mitigate a specified side effect while preserving therapeutic function.
OpenAI Blog
Apr 24, 2024
Accelerating the development of life-saving treatments
Accelerating the development of life-saving treatments.
arXiv AI
Sep 15
LabAgent: Customize Any Research Hubs for Scientific Discoveries Using AI Agents
arXiv:2609.13437v1 Announce Type: new Abstract: Scientific research is a continuous process that emphasizes inheritance. Methods developed by predecessors are often expanded upon by new researchers t...
arXiv Computation and Language
Sep 14
From Bench-to-Bedside: A Review of Clinical Trials in Drug Discovery and Development
arXiv:2412.09378v4 Announce Type: replace-cross Abstract: Clinical trials bridge basic research and clinical application, serving as essential steps in drug development. This review examines clinical...
OpenAI Blog
Sep 12, 2024
Decoding genetics with OpenAI o1
Geneticist Catherine Brownstein demonstrates how OpenAI o1 can speed up the process of diagnosing rare medical challenges.
OpenAI Blog
Sep 10
How a researcher uses Codex and ChatGPT to search for new antimicrobial molecules
César de la Fuente’s laboratory employs Codex and ChatGPT to explore both living and extinct genomes in search of novel antimicrobial molecules. By leveraging these AI tools, the team aims to identify candidates that could help combat drug‑resistant infections.
arXiv Computation and Language
Sep 21
TrialAtlas: Multi-Agent Research Organization for Clinical Trial Design and Optimization
arXiv:2609.21859v1 Announce Type: new Abstract: Nearly 90% of drugs entering clinical development ultimately fail, despite billions of dollars in investment. Pharmaceutical companies therefore rely o...
OpenAI Blog
Aug 22, 2025
Accelerating life sciences research
Discover how a specialized AI model, GPT-4b micro, helped OpenAI and Retro Bio engineer more effective proteins for stem cell therapy and longevity research.